Advocacy groups who spoke before the house Judiciary Committee. Theyll talk about ways to improve Police Relations within the community and increase accountability among Law Enforcement. This is three hours and 40 minutes. House committee on the judiciary will come to order. The chair is authorized to declare recesses at any time. Welcome to the oversight hearing on Police Practices. Before we begin, i want to briefly recognize susan jensen whose last day on the committee after more than 20 years of service is tomorrow. Susan is highly respected on both sides of the aisle, as one of the preeminent experts on bankruptly, Administrative Law and the federal court system. It is a testament to her knowledge and fairness she worked as a senior counsel for republican and democratic chairs of this committee. First hired by former chair henry hyde for her expertise in bankruptcy law, susan moved to the democratic staff under john conyers, where she expanded her port follow to include Administra
The Current System at the United States food and Drug Administration to review, approve and update over the counter drugs. This hearing provides us and the American Public with an opportunity to better understand the food and Drug Administration regulatory pram work to regulate over the counter drugs and consider a proposal to reform the monograph system. Today we will convene two panels of witnesses. First i want to welcome dr. Woodcock back to the subcommittee this morning. Later well hear from representatives of other key stake holders. And commend all for their efforts throughout the negotiation process. And for offering their insight to the committee. Both the energy and Commerce Health subcommittee and full committee have a strong record of by partisan ship on Public Health issues. Such as cures. The fda reauthorizization act and i hope to add to the record of success with todays hearing. Over the counter drug products treat a wide variety of ailments. Time and again consumers se
Public discussion on modernizing the Current System at the United States food and Drug Administration to review, approve and update over the counter drugs. This hearing provides us and the American Public with an opportunity to better understand the food and Drug Administration regulatory pram work to regulate over the counter drugs and consider a proposal to reform the monograph system. Today we will convene two panels of witnesses. First i want to welcome dr. Woodcock back to the subcommittee this morning. Later well hear from representatives of other key stake holders. And commend all for their efforts throughout the negotiation process. And for offering their insight to the committee. Both the energy and Commerce Health subcommittee and full committee have a strong record of by partisan ship on Public Health issues. Such as cures. The fda reauthorizization act and i hope to add to the record of success with todays hearing. Over the counter drug products treat a wide variety of ailm
Of the administration. He has been a little bit more aggressive, little bit more outspoken in the past and i think thats more his character to be more pointed and to be more pointed i guess. Martha roby has been very stick to the facts and i think im hitting everybody but a mix of folks that are hoping to represent the full crosssection of the house and also there was some controversy and there were some criticism from people like therell issa who is a relatively controversial member of the house says none to be in sparring contest with the administration. There was pushed back from him that he was shut out of we thought would be as committee after he was the former chairman of the oversight committee. So there was an effort clearly made here from the republican side while certainly aggressive and active not overly partisan and not overly controversial. Host lets look at the democrats. Four of the five democratic members are also Ranking Members of other committees and clearly the demo